Get started
Author

Rushi Shah

Observed names: R. Shah, Rushi P. Shah
ORCID: 0009-0000-8338-5628
Observed ORCID: 0009-0000-8338-5628
OpenAlex ID: A5101848768
Re-Evaluating Chemotherapy Dosing Strategies for Ovarian Cancer: Impact of Sarcopenia
2023 · Rushi Shah, Clarissa Polen-De, et al. · Current Oncology · 12
PDF
Real-world outcomes of neoadjuvant chemotherapy for advanced ovarian cancer: What happens to patients who never undergo surgery?
2025 · Kelly H. Bruce, Conway Xu, et al. · Gynecologic Oncology · 4
Incident reporting and outcomes of gastrointestinal adverse events with immune checkpoint inhibitors.
2025 · Nikhil Kumar Kotla, Charmi Bhanushali, et al. · Journal of Clinical Oncology · 1
PDF
Abstract #42: Real-world outcomes of neoadjuvant chemotherapy for ovarian cancer: What happens to patients who never undergo surgery?
2024 · Kelly Bruce, Conway Xu, et al. · Gynecologic Oncology Reports · 1
Inpatient outcomes of diabetic ketoacidosis complicating pancreatic cancer: a national inpatient sample analysis
2026 · Rushi Shah, Tanisha Vora · Diabetes & Metabolism
POSTER: MPN-847: In-Hospital Mortality and 30-Day Readmissions in Patients With Myeloproliferative Neoplasm Hospitalized With NSTEMI: A Nationwide Analysis Stratified by Revascularization Strategy
2026 · Parjanya Bhatt, Shivam Mehta, et al. · Clinical Lymphoma Myeloma & Leukemia
POSTER: MPN-672: Venous Thrombotic Outcomes in Pregnant Patients With Myeloproliferative Neoplasms: A Propensity Score-Matched Analysis
2026 · Rushi Shah, Nikhil Vojjal, et al. · Clinical Lymphoma Myeloma & Leukemia
POSTER: AML-849: Prevalence of Standard Modifiable Risk Factors and Associated Cardiovascular Events Among Patients Hospitalized With Acute Myeloid Leukemia: A Nationwide Inpatient Analysis (2016–2022)
2026 · Parjanya Bhatt, Shivam Mehta, et al. · Clinical Lymphoma Myeloma & Leukemia
Luspatercept and thrombotic events in patients with myelodysplastic syndrome: a target trial emulation framework using TriNetX database
2026 · Nikhil Vojjala, Mahmoud Nassar, et al. · Leukemia & lymphoma/Leukemia and lymphoma
Association of GLP-1 receptor agonist exposure with mortality, infectious, and hematologic outcomes in chronic lymphocytic leukemia: A real-world retrospective TriNetX study.
2026 · Sai Sushrutha Mudupula Vemula, Safa Saadat Afridi, et al. · Journal of Clinical Oncology
Temporal trends in cardiovascular and cerebrovascular mortality among U.S. decedents with malignant neoplasms of the bronchus and lung, 1999–2020.
2026 · Avantika Chawla, Rushi Shah, et al. · Journal of Clinical Oncology
PDF
Drivers of early readmission and mortality after metastatic spinal cord compression in cervical cancer: Real-world evidence on disease progression, infection, and palliative gaps.
2026 · Rushi Shah, Dakshin Sitaram Padmanabhan, et al. · Journal of Clinical Oncology
Efficacy of immune therapy–based regimens in sarcomatoid lung cancer: A systematic review and meta-analysis.
2026 · Sai Sushrutha Mudupula Vemula, Faiza Kamal, et al. · Journal of Clinical Oncology
Inpatient outcomes among early-onset breast cancer hospitalizations with metabolic dysfunction–associated liver disease: A national estimate.
2026 · Sharanya Tripathi, Edwin Saji, et al. · Journal of Clinical Oncology
Racial demographic reporting in clinical trials supporting NCCN NSCLC guidelines.
2026 · Soumith Sanka, Sai Sushrutha Mudupula Vemula, et al. · Journal of Clinical Oncology
HSR26-207: Real-World Survival and Toxicity Outcomes of Tarlatamab in Relapsed or Refractory Small-Cell Lung Cancer: A Multicenter TriNetX Analysis Across Academic and Non-Academic Centers
2026 · Sai Sushrutha Mudupula Vemula, Safa Afridi, et al. · Journal of the National Comprehensive Cancer Network
Helicobacter pylori and risk of esophageal cancer: A meta-analysis.
2026 · Maitri Shah, Rushi Shah, et al. · Journal of Clinical Oncology
P3.12.42 Concurrent KRAS Mutations Render Single-Agent EGFR Inhibitors Futile in Advanced NSCLC
2025 · I. Aza, M. Nagasaka, et al. · Journal of Thoracic Oncology
Trends and disparities in cardiovascular mortality among patients with hematological malignancies: A 22-year CDC-WONDER analysis (1999-2020).
2025 · Roopeessh Vempati, Kanika Goyal, et al. · Journal of Clinical Oncology
PDF
Trends of gastrointestinal secondary primary malignancy in chronic lymphocytic leukemia patients from 2000-2021: Surveillance, Epidemiology, and End Results (SEER) database.
2025 · Rakshana Ravichandran, Jayalekshmi Jayakumar, et al. · Journal of Clinical Oncology
Works count: 20
Citation count: 18
H-index: 2
I10-index: 1
Year
Topic
Type